BAXTER INTERNATIONAL INC. : Baxter and Onconova Announce European …

Rigosertib is currently being evaluated in a Phase III clinical trial in 270 MDS patients who have failed or relapsed after receiving current therapeutic …
See all stories on this topic »

Share/Bookmark

Myelodysplastic Syndromes (MDS) Linked to Abnormal Stem Cells …

Home ? News ? Clinical Trials ? Myelodysplastic. … “Our study offers new hope that MDS can be more effectively treated, with therapies that specifically target genes that are deregulated in early stem and progenitor cells,” said Dr. Steidl.Drugs.com – Clinical Trials
See all stories on this topic »

Myelodysplastic Syndromes (MDS) Linked to Abnormal Stem Cells

In the current study, lead author Britta Will, Ph.D., research associate in the department of cell biology, and her colleagues analyzed bone marrow stem cells and progenitor cells (i.e., cells formed by stem cells) from 16 patients with various types …
See all stories on this topic »

Myelodysplastic SyndromesMDS Linked to … – Applied Clinical Trials

Developments news and strategies for drug development specific to phase I through Phase III global clinical trial management execution project management …
See all stories on this topic »

Share/Bookmark

clinical trials foto 14

MDS Clinical Research Consortium | Aplastic Anemia & MDS …

The MDS Clinical Research Consortium is an unprecedented sixinstitution consortium designed to undertake unique studies and trials to significantly advance …
See all stories on this topic »

Share/Bookmark

Addition Of NeoRecormon May Make Vidaza Treatment More Tolerable …

Results of a French Phase 2 clinical trial indicate that the addition of the … (ESAs) are used in myelodysplastic syndromes (MDS) patients to prevent low …
See all stories on this topic »

Treating Lower Risk MDS in 2012: Applying the Most Current …

Treating Lower Risk MDS in 2012: Applying the Most Current Clinical Research to Patient Care. Presentation Link: View this webcast on our Online Learning …
See all stories on this topic »

Share/Bookmark

DaVita Clinical Research’s New Denver Facility Hires Leading Talent

MINNEAPOLIS—DaVita Clinical Research (DCR) has hired four individuals to ignite … employers Harris Laboratories, MDS Pharma Services and Radiant Research.
See all stories on this topic »

MDS researchers join forces to advance patient treatments an NEW …

MDS researchers join forces to advance patient treatments an NEW … NEW YORKJune 18 2012 NewYorkPresbyterianWeill Cornell Medical Center is one of six …
See all stories on this topic »

Share/Bookmark

Horse ATG in Patients With AA or Low/Int-1 Risk … – Clinical Trials.gov

The goal of this clinical research study is to learn if horse anti-thymocyte globulin … This may help to improve low blood counts in AA and in some cases of MDS.
See all stories on this topic »

Weill Cornell Medical College Selected to Join New MDS Clinical …

NewYork Presbyterian Hospital/Weill Cornell Medical Center.
See all stories on this topic »

Share/Bookmark

The Obesity Race: Update, Part 2

MDs start to prescribe them less and less because of this. … Dropout rates from clinical trials that also suggest poor customer demand: Second, …
See all stories on this topic »

PharmaLive Astex Pharmaceuticals Announces Initiation of the Phase …

We are pleased with the advancement of SGI110 into the Phase 2 segment of the clinical trial The allowance of treatmentnaive MDS and elderly AML patients …
See all stories on this topic »

Share/Bookmark

Myelodysplastic Syndrome Treated with Deferasirox Shows Beneficial …

Deferasirox, the drug tested in the clinical trial, was aimed at reducing the … “The majority of patients with MDS require red blood cell transfusions for …
See all stories on this topic »

mds Top Search aePiot – Preclinical-clinical-news

mds Top Search aePiot Cleveland Clinic selected to participate in National mds Clinical Research Consortium 7 June 2012 1141 am. Cleveland Clinic Clevel…
See all stories on this topic »

Share/Bookmark

MDS researchers join forces to advance patient treatments an NEW …

NEW YORKJune 18 2012 NewYorkPresbyterianWeill Cornell Medical Center is one of six institutions selected to join the newlyfounded MDS Clinical Research …
See all stories on this topic »

“Good Morning America’s” Robin Roberts Develops MDS After Breast

Information about clinical trials for MDS can be found at: http://cancer.gov/ clinicaltrials/search/results?protocolsearchid=10552715. Our best wishes to Robin for …
See all stories on this topic »

Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re …

“We are re-evaluating the tostedostat phase III clinical trial design and …. with hypomethylating agents in treating AML and/or MDS, that the studies of …
See all stories on this topic »

NewYorkPresbyterianWCMC join new MDS Clinical Research Consortium

NewYork-Presbyterian/Weill Cornell Medical Center is one of six institutions selected to join the newly-founded MDS Clinical Research Consortium.
See all stories on this topic »

News | Weill Cornell Medical College | Cornell University

The new Consortium will help fill a major gap in the United States for MDS- related clinical …
See all stories on this topic »

Astex Commences Phase 2 Dose Expansion Segment Of Clinical Trial …

… segment of the clinical trial of SGI-110, a novel hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes, or MDS, …
See all stories on this topic »

Incoming search engine referrals:

• of six institutions selected to join the new national mds clinical research consortium

Share/Bookmark

mds Top Search aePiot

Cleveland Clinic selected to participate in National mds Clinical Research Consortium 7 June 2012 1141 am. Cleveland Clinic Cleveland Clinic will …
See all stories on this topic »

New Data Show Majority of Patients with aHUS Experienced Systemic …

(4) The safety and adverse event profile for Soliris was consistent with that reported in adult Phase 3 PNH clinical trials.(4) aHUS is a chronic, …
See all stories on this topic »

MDS researchers join forces to advance patient treatments and outcomes

NewYorkPresbyterianWeill Cornell Medical Center is 1 of 6 institutions selected to participate in new MDS clinical research consortium …
See all stories on this topic »

Study of Cell Therapeutics’ Tosedostat for Elderly Patients with …

Those eligible for the trial are adults with newly-diagnosed AML (including those with high-risk MDS). Patients with certain favorable AML features would be …
See all stories on this topic »

Barbra Streisand Takes Aim at Eliminating ‘Yentl Syndrome’ in …

After supporting a regenerative medicine research fund in 2007, then underwriting The Barbra … many clinical trials of various heart drugs lacked adequate …
See all stories on this topic »

Incoming search engine referrals:

• aepiot

Share/Bookmark